Large-scale testing (Phase 3)Study completedNCT03777657
What this trial is testing
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
Who this might be right for
Gastric, or Gastroesophageal Junction Adenocarcinoma
BeiGene 997